Human brucellosis

Lancet Infectious Diseases

Volumn 7, Issue 12, 2007, Pages 775-786

  Franco, María Pía ^a   Mulder, Maximilian ^b   Gilman, Robert H ^c,d,e   Smits, Henk L ^f  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f ROYAL TROPICAL INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DOXYCYCLINE; GENTAMICIN; MACROLIDE; MINOCYCLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RHEUMATOID FACTOR; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE;

AGGLUTINATION TEST; ANEMIA; ARTHRALGIA; ARTHRITIS; BLOOD CULTURE; BRUCELLOSIS; CHILL; COMBINATION CHEMOTHERAPY; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DRUG MONITORING; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HEALTH PROGRAM; HEPATOMEGALY; HUMAN; LEUKOCYTOSIS; LEUKOPENIA; PATHOGENESIS; PATHOGENICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; SPLENOMEGALY; SWEATING; THROMBOCYTOPENIA; THROMBOCYTOSIS; TREATMENT RESPONSE;

ANIMALS; BRUCELLA; BRUCELLOSIS; DEVELOPING COUNTRIES; DISEASE RESERVOIRS; HUMANS; ZOONOSES;

EID: 36348974525     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70286-4     Document Type: Review

References (154)

1. Pappas G., Papadimitriou P., Akritidis N., Christou L., and Tsianos E. The new global map of human brucellosis. Lancet Infect Dis 6 (2006) 91-99
2. Greenfield R., Drevets D., Machado L., et al. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci 323 (2002) 299-315
3. McDermott J., and Arimi S. Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet Microbiol 90 (2002) 111-134
4. Godfroid J., Cloeckaert A., Liautard J., et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 36 (2005) 313-326
5. Castillo J.C., Franquelo F.C., Marquez S.H., et al. Socioeconomic effects of human brucellosis. Rev Clin Esp 185 (1989) 459-463
6. Pappas G., Akritidis N., Bosilkovski M., and Tsianos E. Brucellosis. N Engl J Med 352 (2005) 2325-2336
7. Roushan M.H., Mohrez M., Gangi S.S., Amiri M.S., and Hajiahmadi M. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect 132 (2004) 1109-1114
8. Colmenero J., Reguera J., Cabrera F., et al. Serology, clinical manifestations and treatment of brucellosis in different age groups. Infection 18 (1990) 152-156
9. Kokoglu O., Hosoglu S., Geyik M., et al. Clinical and laboratory features of brucellosis in two university hospitals in southeast Turkey. Trop Doct 36 (2006) 49-51
10. Memish Z., Mah M., Al Mahmoud S., Al Shaalan M., and Khan M. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J Infect 40 (2000) 59-63
11. Delrue R., Lestrate P., Tibor A., Letesson J., and De Bolle X. Brucella pathogenesis, genes identified from random large-scale screens. FEMS Microbiol Lett 231 (2004) 1-12
12. Lapaque N., Moriyon I., Moreno E., and Gorvel J. Brucella lipopolysaccharide acts as a virulence factor. Curr Opin Microbiol 8 (2005) 60-66
13. Porte F., Naroeni A., Ouahrani-Bettache S., and Liautard J. Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages. Infect Immun 71 (2003) 1481-1490
14. Goldstein J., Hoffman T., Frasch C., et al. Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B abortus or LPS from B abortus as a carrier in vaccines. Infect Immun 60 (1992) 1385-1389
15. Forestier C., Moreno E., Pizarro-Cerda J., and Gorvel J. Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study. J Immunol 162 (1999) 6784-6791
16. Gross A., Terraza A., Ouahrani-Bettache S., Liautard J., and Dornand J. In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infect Immun 8 (2000) 342-351
17. Tolomeo M., Di Carlo P., Abbadessa V., et al. Monocyte and lymphocyte apoptosis resistance in acute and chronic brucellosis and its possible implications in clinical management. Clin Infect Dis 36 (2003) 1533-1538
18. Ugalde J., Comerci D., Leguizamon M., and Ugalde R. Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine. Infect Immun 71 (2003) 6264-6269
19. Guzman-Verri C., Manterola L., Sola-Landa A., et al. The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae. Proc Natl Acad Sci USA 99 (2002) 12375-12380
20. Lopez-Goni I., Guzman-Verri C., Manterola L., et al. Regulation of brucella virulence by the two-component system BvrR/BvrS. Vet Microbiol 90 (2002) 329-339
21. O'Callaghan D., Cazevieille C., Allardet-Servent A., et al. A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis. Mol Microbiol 33 (1999) 1210-1220
22. Boschiroli M., Ouahrani-Bettache S., Foulongne V., et al. Type IV secretion and brucella virulence. Vet Microbiol 90 (2002) 341-348
23. Celli J., Salcedo S., and Gorvel J. Brucella coopts the small GTPase Sar1 for intracellular replication. Proc Natl Acad Sci USA 102 (2005) 1673-1678
24. Boschiroli M., Ouahrani-Bettache S., Foulongne V., et al. The Brucella suis virB operon is induced intracellularly in macrophages. Proc Natl Acad Sci USA 99 (2002) 1544-1549
25. Arenas G., Staskevich A., Aballay A., and Mayorga L. Intracellular trafficking of Brucella abortus in J774 macrophages. Infect Immun 68 (2000) 4255-4263
26. Pizarro-Cerda J., Meresse S., Parton R., et al. Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect Immun 66 (1998) 5711-5724
27. Porte F., Liautard J., and Kohler S. Early acidification of phagosomes containing Brucella suis is essential for intracellular survival in murine macrophages. Infect Immun 67 (1999) 4041-4047
28. Watarai M. Interaction between Brucella abortus and cellular prion protein in lipid raft microdomains. Microbes Infect 6 (2004) 93-100
29. Mantur B., Biradar M., Bidri R., et al. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area. J Med Microbiol 55 (2006) 897-903
30. Garcia P.B., Pelayo R.R.-C., Gil Extremera B., et al. Study of 1595 brucellosis cases in the Almeria province (1972-1998) based on epidemiological data from disease reporting. Rev Clin Esp 202 (2002) 577-582
31. Giannakopoulos I., Nikolakopoulou N., Eliopoulou M., et al. Presentation of childhood brucellosis in western Greece. Jpn J Infect Dis 59 (2006) 160-163
32. Mantur B., Akki A., Mangalgi S., et al. Childhood brucellosis-a microbiological, epidemiological and clinical study. J Trop Pediatr 50 (2004) 153-157
33. Andriopoulos P., Tsironi M., Deftereos S., Aessopos A., and Assimakopoulos G. Acute brucellosis: presentation, diagnosis, and treatment of 144 cases. Int J Infect Dis 11 (2007) 52-57
34. Sohn A., Probert W., Glaser C., et al. Human neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp. Emerg Infect Dis 9 (2003) 485-488
35. Whatmore A., Perrett L., and Macmillan A. Characterisation of the genetic diversity of Brucella by multilocus sequencing. BMC Microbiol 7 (2007) 34
36. Troy S., Rickman L., and Davis C. Brucellosis in San Diego: epidemiology and species-related differences in acute clinical presentations. Medicine (Baltimore) 84 (2005) 174-187
37. Almuneef M., Memish Z., Balkhy H., et al. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol Infect 132 (2004) 533-540
38. Ruiz-Mesa J., Sanchez-Gonzalez J., Reguera J., Martin L., Lopez-Palmero S., and Colmenero J. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect 11 (2005) 221-225
39. Tsolia M., Drakonaki S., Messaritaki A., et al. Clinical features, complications and treatment outcome of childhood brucellosis in central Greece. J Infect 44 (2002) 257-262
40. Yetkin M., Bulut C., Erdinc F., Oral B., and Tulek N. Evaluation of the clinical presentations in neurobrucellosis. Int J Infect Dis 10 (2006) 446-452
41. Kerem E., Diav O., Navon P., and Branski D. Pleural fluid characteristics in pulmonary brucellosis. Thorax 49 (1994) 89-90
42. Uddin M., Sanyal S., Mustafa A., et al. The role of aggressive medical therapy along with early surgical intervention in the cure of Brucella endocarditis. Ann Thorac Cardiovasc Surg 4 (1998) 209-213
43. Aydin M., Fuat Yapar A., Savas L., et al. Scintigraphic findings in osteoarticular brucellosis. Nucl Med Commun 6 (2005) 639-647
44. Cascio A., Iaria C., Campenni A., Blandino A., and Baldari S. Use of sulesomab in the diagnosis of brucellar spondylitis. Clin Microbiol Infect 10 (2004) 1020-1022
45. Adaletli I., Albayram S., Gurses B., et al. Vasculopathic changes in the cerebral arterial system with neurobrucellosis. AJNR Am J Neuroradiol 27 (2006) 384-386
46. Al-Sous M., Bohlega S., Al-Kawi M., Alwatban J., and McLean D. Neurobrucellosis: clinical and neuroimaging correlation. AJNR Am J Neuroradiol 25 (2004) 395-401
47. Kula S., Erer D., Buyukates M., et al. Brucella endocarditis: case report and review of the literature. J Heart Valve Dis 10 (2001) 486-488
48. Giannacopoulos I., Eliopoulou M., Ziambaras T., and Papanastasiou D. Transplacentally transmitted congenital brucellosis due to Brucella abortus. J Infect 45 (2002) 209-210
49. Palanduz A., Palanduz S., Guler K., and Guler N. Brucellosis in a mother and her young infant: probable transmission by breast milk. Int J Infect Dis 4 (2000) 55-56
50. Espadero D.B., Arroyo Carrera I., Lopez Rodriguez M., Rodriguez J.L., and Lopez Lafuente A. The transmission of brucellosis via breast feeding. A report of 2 cases. An Esp Pediatr 48 (1998) 60-62
51. Celebi G., Kulah C., Kilic S., and Ustundag G. Asymptomatic Brucella bacteraemia and isolation of Brucella melitensis biovar 3 from human breast milk. Scand J Infect Dis 39 (2007) 205-208
52. Al-Kharfy T. Neonatal brucellosis and blood transfusion: case report and review of the literature. Ann Trop Paediatr 21 (2001) 349-352
53. Doganay M., Aygen B., and Esel D. Brucellosis due to blood transfusion. J Hosp Infect 49 (2001) 151-152
54. Ruben B., Band J., Wong P., and Colville J. Person-to-person transmission of Brucella melitensis. Lancet 337 (1991) 14-15
55. Ozturk R., Mert A., Kocak F., et al. The diagnosis of brucellosis by use of BACTEC 9240 blood culture system. Diagn Microbiol Infect Dis 44 (2002) 133-135
56. Durmaz G., Us T., Aydinli A., et al. Optimum detection times for bacteria and yeast species with the BACTEC 9120 aerobic blood culture system: evaluation for a 5-year period in a Turkish university hospital. J Clin Microbiol 41 (2003) 819-821
57. Navas E., Guerrero A., Cobo J., and Loza E. Faster isolation of Brucella spp from blood by isolator compared with BACTEC NR. Diagn Microbiol Infect Dis 16 (1993) 79-81
58. Cockerill III F., Wilson J., Vetter E., et al. Optimal testing parameters for blood cultures. Clin Infect Dis 38 (2004) 1724-1730
59. Mantur B., and Mangalgi S. Evaluation of conventional castaneda and lysis centrifugation blood culture techniques for diagnosis of human brucellosis. J Clin Microbiol 42 (2004) 4327-4328
60. Yagupsky P. Detection of brucellae in blood cultures. J Clin Microbiol 37 (1999) 3437-3442
61. Ruiz-Castañeda M. A practical method for routine blood cultures in brucellosis. Proc Soc Exp Biol Med 86 (1954) 154-155
62. Ganado W., and Bannister W. Bacteraemia in human brucellosis. BMJ 1 (1960) 601-603
63. Bannatyne R., Jackson M., and Memish Z. Rapid diagnosis of brucella bacteremia by using the BACTEC 9240 system. J Clin Microbiol 35 (1997) 2673-2674
64. Gotuzzo E., Carrillo C., Guerra J., and Llosa L. An evaluation of diagnostic methods for brucellosis-the value of bone marrow culture. J Infect Dis 153 (1986) 122-125
65. Doganay M., and Aygen B. Human brucellosis: an overview. Int J Infect Dis 7 (2003) 173-182
66. Gaviria-Ruiz M., and Cardona-Castro N. Evaluation and comparison of different blood culture techniques for bacteriological isolation of Salmonella typhi and Brucella abortus. J Clin Microbiol 33 (1995) 868-871
67. Deepak S., Bronson S., Sibi, Joseph W., and Thomas M. Brucella isolated from bone marrow. J Assoc Physicians India 51 (2003) 717-718
68. Etemadi H., Raissadat A., Pickett M., Zafari Y., and Vahedifar P. Isolation of Brucella spp from clinical specimens. J Clin Microbiol 20 (1984) 586
69. Doern G. Detection of selected fastidious bacteria. Clin Infect Dis 30 (2000) 166-173
70. Robichaud S., Libman M., Behr M., and Rubin E. Prevention of laboratory-acquired brucellosis. Clin Infect Dis 38 (2004) e119-e122
71. Noviello S., Gallo R., Kelly M., et al. Laboratory-acquired brucellosis. Emerg Infect Dis 10 (2004) 1848-1850
72. Yagupsky P., and Baron E. Laboratory exposures to brucellae and implications for bioterrorism. Emerg Infect Dis 11 (2005) 1180-1185
73. Miller C., Songer J., and Sullivan J. A twenty-five year review of laboratory-acquired human infections at the National Animal Disease Center. Am Ind Hyg Assoc J 48 (1987) 271-275
74. Turkmani A., Ioannidis A., Christidou A., et al. In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics. Ann Clin Microbiol Antimicrob 5 (2006) 24
75. Akova M., Gur D., Livermore D., Kocagoz T., and Akalin H. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. Antimicrob Agents Chemother 43 (1999) 1298-1300
76. Ariza J., Bosch J., Gudiol F., Liñares J., Viladrich P., and Martín R. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Antimicrob Agents Chemother 30 (1986) 958-960
77. Al Dahouk S., Tomaso H., Nockler K., Neubauer H., and Frangoulidis D. Laboratory-based diagnosis of brucellosis-a review of the literature. Part II: serological tests for brucellosis. Clin Lab 49 (2003) 577-589
78. Ariza J., Pellicer T., Pallares R., Foz A., and Gudiol F. Specific antibody profile in human brucellosis. Clin Infect Dis 14 (1992) 131-140
79. Nielsen K., Smith P., Widdison J., et al. Serological relationship between cattle exposed to Brucella abortus, Yersinia enterocolitica O:9 and Escherichia coli O157:H7. Vet Microbiol 100 (2004) 25-30
80. Serra J., and Vinas M. Laboratory diagnosis of brucellosis in a rural endemic area in northeastern Spain. Int Microbiol 7 (2004) 53-58
81. Maichomo M., McDermott J., Arimi S., and Gathura P. Assessment of the Rose-Bengal plate test for the diagnosis of human brucellosis in health facilities in Narok district, Kenya. East Afr Med J 75 (1998) 219-222
82. Blasco J., Garin-Bastuji B., Marin C., et al. Efficacy of different Rose Bengal and complement fixation antigens for the diagnosis of Brucella melitensis infection in sheep and goats. Vet Rec 134 (1994) 415-420
83. Mantecon M., Gutierrez P., del Pilar Zarzosa M., et al. Utility of an immunocapture-agglutination test and an enzyme-linked immunosorbent assay test against cytosolic proteins from Brucella melitensis B115 in the diagnosis and follow-up of human acute brucellosis. Diagn Microbiol Infect Dis 55 (2006) 27-35
84. Araj G., Kattar M., Fattouh L., Bajakian K., and Kobeissi S. Evaluation of the PANBIO brucella immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays for diagnosis of human brucellosis. Clin Diagn Lab Immunol 12 (2005) 1334-1335
85. Orduna A., Almaraz A., Prado A., et al. Evaluation of an immunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis. J Clin Microbiol 38 (2000) 4000-4005
86. Baldi P., Araj G., Racaro G., Wallach J., and Fossati C. Detection of antibodies to brucella cytoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis. Clin Diagn Lab Immunol 6 (1999) 756-759
87. Lucero N., Escobar G., Ayala S., Paulo P.S., and Nielsen K. Fluorescence polarization assay for diagnosis of human brucellosis. J Med Microbiol 52 (2003) 883-887
88. Irmak H., Buzgan T., Evirgen O., et al. Use of a new, simple and rapid diagnostic test, the brucella-IgM and IgG flow assays in the serodiagnosis of human brucellosis in an endemic area in eastern Turkey. Am J Trop Med Hyg 70 (2004) 688-694
89. Hasanjani-Roushan M., Soleimani-Amin M., Abdoel T., and Smits H. Application of a rapid and simple brucella-specific IgM and IgG antibody test for the serodiagnosis of brucellosis in a hospital in Iran. Trans R Soc Trop Med Hyg 99 (2005) 744-750
90. Abramson O., Rosenvasser Z., Block C., and Dagan R. Detection and treatment of brucellosis by screening a population at risk. Ped Infect Dis J 10 (1991) 434-438
91. Almuneef M., Memish Z., Balkhy H., et al. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol Infect 132 (2004) 533-540
92. Alsubaie S., Almuneef M., Alshaalan M., et al. Acute brucellosis in Saudi families: relationship between brucella serology and clinical symptoms. Int J Infect Dis 9 (2005) 218-224
93. Buchanan T., and Faber L. 2-mercaptoethanol brucella agglutination test: usefulness for predicting recovery from brucellosis. J Clin Microbiol 11 (1980) 691-693
94. Nockler K., Scholz H., Tomaso H., Bogumil R., and Neubauer H. Immunoproteomic characterization of Brucella abortus 1119-3 preparations used for the serodiagnosis of brucella infections. J Immunol Methods 309 (2006) 34-47
95. Bricker B. PCR as a diagnostic tool for brucellosis. Vet Microbiol 90 (2002) 435-446
96. Baily G., Krahn J., Drasar B., and Stoker N. Detection of Brucella melitensis and Brucella abortus by DNA amplification. J Trop Med Hyg 95 (1992) 271-275
97. Bardenstein S., Mandelboim M., Ficht T., Baum M., and Banai M. Identification of the Brucella melitensis vaccine strain Rev1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene. J Clin Microbiol 40 (2002) 1475-1480
98. Cloeckaert A., Grayon M., and Grepinet O. An IS711 element downstream of the bp26 gene is a specific marker of Brucella spp isolated from marine mammals. Clin Diagn Lab Immunol 7 (2000) 835-839
99. Leal-Klevezas D., Martinez-Vazquez I., Lopez-Merino A., and Martinez-Soriano J. Single-step PCR for detection of Brucella spp from blood and milk of infected animals. J Clin Microbiol 33 (1995) 3087-3090
100. Herman L., and De Ridder H. Identification of Brucella spp by using the polymerase chain reaction. Appl Environ Microbiol 58 (1992) 2099-2101
101. Fekete A., Bantle J., Halling S., and Sanborn M. Preliminary development of a diagnostic test for brucella using polymerase chain reaction. J Appl Bacteriol 69 (1990) 216-227
102. Queipo-Ortuño M., Morata P., Ocon P., Manchado P., and Colmenero J. Rapid diagnosis of human brucellosis by peripheral-blood PCR assay. J Clin Microbiol 35 (1997) 2927-2930
103. Zerva L., Bourantas K., Mitka S., Kansouzidou A., and Legakis N. Serum is the preferred clinical specimen for diagnosis of human brucellosis by PCR. J Clin Microbiol 39 (2001) 1661-1664
104. Vrioni G., Gartzonika C., Kostoula A., et al. Application of a polymerase chain reaction enzyme immunoassay in peripheral whole blood and serum specimens for diagnosis of acute human brucellosis. Eur J Clin Microbiol Infect Dis 23 (2004) 194-199
105. Boom R., Sol C., Salimans M., et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28 (1990) 495-503
106. Mitka S., Anetakis C., Souliou E., Diza E., and Kansouzidou A. Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods. J Clin Microbiol 45 (2007) 1211-1218
107. Colmenero J., Queipo-Ortuno M., Maria Reguera J., et al. Chronic hepatosplenic abscesses in brucellosis. Clinico-therapeutic features and molecular diagnostic approach. Diagn Microbiol Infect Dis 42 (2002) 159-167
108. Morata P., Queipo-Ortuño M., Reguera J., et al. Diagnostic yield of a PCR assay in focal complications of brucellosis. J Clin Microbiol 39 (2001) 3743-3746
109. Colmenero J., Queipo-Ortuno M., Reguera J., et al. Real time polymerase chain reaction: a new powerful tool for the diagnosis of neurobrucellosis. J Neurol Neurosurg Psychiatry 76 (2005) 1025-1027
110. Queipo-Ortuno M., Colmenero J., Baeza G., and Morata P. Comparison between LightCycler real-time polymerase chain reaction (PCR) assay with serum and PCR-enzyme-linked immunosorbent assay with whole blood samples for the diagnosis of human brucellosis. Clin Infect Dis 40 (2005) 260-264
111. Debeaumont C., Falconnet P., and Maurin M. Real-time PCR for detection of Brucella spp DNA in human serum samples. Eur J Clin Microbiol Infect Dis 24 (2005) 842-845
112. Redkar R., Rose S., Bricker B., and DelVecchio V. Real-time detection of Brucella abortus, Brucella melitensis and Brucella suis. Mol Cell Probes 15 (2001) 43-52
113. Newby D., Hadfield T., and Roberto F. Real-time PCR detection of Brucella abortus: a comparative study of SYBR green I, 5′-exonuclease, and hybridization probe assays. Appl Environ Microbiol 69 (2003) 4753-4759
114. Probert W., Schrader K., Khuong N., Bystrom S., and Graves M. Real-time multiplex PCR assay for detection of Brucella spp, B abortus, and B melitensis. J Clin Microbiol 42 (2004) 1290-1293
115. Bogdanovich T., Skurnik M., Lubeck P., Ahrens P., and Hoorfar J. Validated 5′ nuclease PCR assay for rapid identification of the genus brucella. J Clin Microbiol 42 (2004) 2261-2263
116. Nimri L. Diagnosis of recent and relapsed cases of human brucellosis by PCR assay. BMC Infect Dis 3 (2003) 5
117. Navarro E., Segura J., Castano M., and Solera J. Use of real-time quantitative polymerase chain reaction to monitor the evoluation of Brucella melitensis DNA load during therapy and post-treatment follow-up in patients with brucellosis. Clin Infect Dis 42 (2006) 1266-1273
118. Morata P., Queipo-Ortuño M., Reguera J., et al. Posttreatment follow-up of brucellosis by PCR assay. J Clin Microbiol 37 (1999) 4163-4166
119. Maas K., Mendez M., Zavaleta M., et al. Evaluation of brucellosis by PCR and persistence after treatment in patients returning to the hospital for follow-up. Am J Trop Med Hyg 76 (2007) 698-702
120. Bricker B., Ewalt D., and Halling S. Brucella 'HOOF-Prints': strain typing by multi-locus analysis of variable number tandem repeats (VNTRs). BMC Microbiol 3 (2003) 15
121. Whatmore A., Shankster S., Perrett L., et al. Identification and characterization of variable-number tandem-repeat markers for typing of Brucella spp. J Clin Microbiol 44 (2006) 1982-1993
122. Vizcaino N., Caro-Hernandez P., Cloeckaert A., and Fernandez-Lago L. DNA polymorphism in the omp25/omp31 family of Brucella spp: identification of a 1.7-kb inversion in Brucella cetaceae and of a 15·1-kb genomic island, absent from Brucella ovis, related to the synthesis of smooth lipopolysaccharide. Microbes Infect 6 (2004) 821-834
123. Cloeckaert A., Verger J., Grayon M., et al. Classification of Brucella spp isolated from marine mammals by DNA polymorphism at the omp2 locus. Microbes Infect 3 (2001) 729-738
124. Cloeckaert A., Grayon M., and Grepinet O. An IS711 element downstream of the bp26 gene is a specific marker of Brucella spp isolated from marine mammals. Clin Diagn Lab Immunol 7 (2000) 835-839
125. Whatmore A., Murphy T., Shankster S., et al. Use of amplified fragment length polymorphism to identify and type brucella isolates of medical and veterinary interest. J Clin Microbiol 43 (2005) 761-769
126. Le Fleche P., Jacques I., Grayon M., et al. Evaluation and selection of tandem repeat loci for a brucella MLVA typing assay. BMC Microbiol 6 (2006) 9
127. Al Dahouk S., Fleche P., Nockler K., et al. Evaluation of brucella MLVA typing for human brucellosis. J Microbiol Methods 69 (2007) 137-145
128. Joint Food and Agriculture Organization (FAO), World Health Organization (WHO). FAO-WHO expert committee on brucellosis. 6th report. WHO technical report series, no 740 (1986), World Health Organization, Geneva 56-57
129. Hasanjani Roushan M., Mohraz M., Hajiahmadi M., Ramzani A., and Valayati A. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis 42 (2006) 1075-1080
130. Falagas M., and Bliziotis I. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Chemother 50 (2006) 22-33
131. Ariza J., Corredoira J., Pallares R., et al. Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis 20 (1995) 1241-1249
132. Solera J., Martinez-Alfaro E., Espinosa A., Castillejos M., Geijo P., and Rodriguez-Zapata M. Multivariate model for predicting relapse in human brucellosis. J Infect 36 (1998) 85-92
133. Solera J., Martinez-Alfaro E., and Saez L. Meta-analysis of the efficacy of the combination of rifampicin and doxycycline in the treatment of human brucellosis. Med Clin (Barc) 102 (1994) 731-738
134. Cascio A., Scarlata F., Giordano S., et al. Treatment of human brucellosis with rifampin plus minocycline. J Chemother 15 (2003) 248-252
135. Haddadi A., Mohraz M., and Marefat M. Study of brucellosis treatment regimens in brucellosis patients in Imam Khomeini Hospital of Tehran. Iranian J Infect Dis Trop Med 20 (2003) 29-32
136. Ranjbar M., Keramat F., Mamani M., et al. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. Int J Infect Dis 111 (2007) 152-156
137. Solera J., Espinosa A., Martínez-Alfaro E., et al. Treatment of human brucellosis with doxycycline and gentamicin. Antimicrob Agents Chemother 41 (1997) 80-84
138. Lecaroz C., Blanco-Prieto M., Burrell M., and Gamazo C. Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin. J Antimicrob Chemother 58 (2006) 549-556
139. Dizer U., Hayat L., Beker C., et al. The effect of the doxycycline-rifampicin and levamisole combination on lymphocyte subgroups and functions of phagocytic cells in patients with chronic brucellosis. Chemotherapy 51 (2005) 27-31
140. Irmak H., Buzgan T., Karahocagil M., et al. The effect of levamisole combined with the classical treatment in chronic brucellosis. Tohoku J Exp Med 201 (2003) 221-228
141. Printzis S., Raptopoulou-Gigi M., Orphanou-Koumerkeridou H., Lagre F., and Goulis G. Immunotherapy in chronic brucellosis. Effect of levamisole and interferon; mechanisms of action and clinical value. Immunopharmacol Immunotoxicol 16 (1994) 679-693
142. Boura P., Tsapas G., Kountouras J., and Zaharioudaki E. Interferon-A 2a administration in chronic anergic brucellosis. Hepatogastroenterology 42 (1995) 919-922
143. Alp E., Koc R., Durak A., et al. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis. BMC Infect Dis 6 (2006) 72-81
144. Doyle T., and Bryan R. Infectious disease morbidity in the US region bordering Mexico, 1990-1998. J Infect Dis 182 (2000) 1503-1510
145. Thapar M., and Young E. Urban outbreak of goat cheese brucellosis. Pediatr Infect Dis 5 (1986) 640-643
146. Al Dahouk S., Nockler K., Hensel A., et al. Human brucellosis in a nonendemic country: a report from Germany, 2002 and 2003. Eur J Clin Microbiol Infect Dis 24 (2005) 450-456
147. Luzzi G., Brindle R., Sockett P., et al. Brucellosis: imported and laboratory-acquired cases, and an overview of treatment trials. Trans R Soc Trop Med Hyg 87 (1993) 138-141
148. Schurig G., Sriranganathan N., and Corbel M. Brucellosis vaccines: past, present and future. Vet Microbiol 90 (2002) 479-496
149. Moriyon I., Grillo M., Monreal D., et al. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res 35 (2004) 1-38
150. Lundervold M., Milner-Gulland E., O'Callaghan C., et al. A serological survey of ruminant livestock in Kazakhstan during post-Soviet transitions in farming and disease control. Acta Vet Scand 45 (2004) 211-224
151. Samartino L. Brucellosis in Argentina. Vet Microbiol 90 (2002) 71-80
152. Luna-Martinez J., and Mejia-Teran C. Brucellosis in Mexico: current status and trends. Vet Microbiol 90 (2002) 19-30
153. Roth F., Zinsstag J., Orkhon D., et al. Human health benefits from livestock vaccination for brucellosis: case study. Bull World Health Organ 81 (2003) 867-876
154. Arimi S., Koroti E., Kang'ethe E., Omore A., and McDermott J. Risk of infection with Brucella abortus and Escherichia coli O157:H7 associated with marketing of unpasteurized milk in Kenya. Acta Trop 96 (2005) 1-8